文献速递临床试验与 GCP

COMMENCE试验:主动脉半弓手术中轻度与中度低温对患者结局的随机对照研究

COMMENCE trial (Comparing hypOtherMic teMperaturEs duriNg hemiarCh surgEry): a randomized controlled trial of mild vs moderate hypothermia on patient outcomes in aortic hemiarch surgery with anterograde cerebral perfusion.
PubMed 文献 · Trials · 2019-12-09

COMMENCE试验是一项多中心、单盲、双臂随机对照研究,纳入282例接受顺行脑灌注下半弓手术的患者,比较轻度(32°C)与中度(26°C)低温停循环对神经损伤和急性肾损伤复合终点的影响。研究期望轻度低温策略能使复合终点绝对风险降低15%,并为首个主动脉手术温度管理指南提供证据。

要点

  • 轻度(32°C)与中度(26°C)低温停循环在主动脉半弓手术中的结局比较尚需随机对照证据
  • 主要终点为神经损伤(短暂性脑缺血发作和/或卒中)与KDIGO 1级及以上急性肾损伤的复合终点
  • 试验计划纳入282例患者,1:1区组随机分组,每例随访60±14天

核心结论

  • 主动脉半弓手术中采用轻度低温(32°C)联合选择性顺行脑灌注能否降低神经损伤和急性肾损伤复合终点尚待该随机对照试验验证。

研究设计与样本

  • 多中心、单盲、双臂随机对照试验,比较轻度低温(32°C)与中度低温(26°C)停循环在主动脉半弓手术中的应用。
  • 计划纳入282例接受半弓手术联合顺行脑灌注的患者,手术当天按1:1区组随机分配至各治疗组。

主要发现

  • 主要终点为神经损伤(短暂性脑缺血发作和/或卒中发生率)与KDIGO 1级或以上急性肾损伤的复合终点。
  • 次要结局包括死亡、体外循环时间、出血、输血率、延长机械通气、心肌梗死、住院时间和生活质量指标。
  • 神经认知功能采用NIHSS、MOCA、BI和MRS等经验证的神经筛查测试评估,急性肾损伤按KDIGO标准基于肌酐升高诊断和分类。
  • 每例患者研究持续时间为60±14天。

关键数值与推荐

  • 轻度低温组目标温度为32°C,中度低温组目标温度为26°C。
  • 主要复合终点包含短暂性脑缺血发作和/或卒中以及KDIGO 1级或以上急性肾损伤。
  • 研究期望轻度低温(32°C)联合选择性顺行脑灌注可使复合结局绝对风险降低15%。

临床怎么用

  • 该试验结果拟用于制定首个主动脉手术温度管理策略指南。
  • 围手术期管理按各参与中心标准治疗进行,手术操作顺序由外科医生决定,但温度和顺行脑灌注实施有强制指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic arch surgery remains the only viable life-saving treatment for aortic arch disease. However, the necessity for cessation of systemic blood flow with hypothermic cardiac arrest carries substantial risk of morbidity and mortality, including poor neurological outcomes and kidney failure. While uncontrolled studies have suggested the safety of operating at warmer temperatures, significant variables remain un-investigated, supporting the need for a randomized clinical trial (RCT) to produce evidence-based guidelines for perfusion strategies in aortic surgery. This study proposes a multi-center RCT in order to compare outcomes of warmer hypothermic strategies during aortic hemiarch surgery on a composite endpoint of neurologic and acute kidney injury (AKI). METHODS/DESIGN: This is a prospective multi-center, single-blind two-arm RCT comparing mild (32 °C) versus moderate (26 °C) hypothermic cardiac arrest in patients (n = 282) undergoing hemiarch surgery with antegrade cerebral perfusion (ACP). The primary endpoint is a composite of neurological injury (incidence of transient ischemic attack and/or stroke) and Kidney Disease Improving Global Outcomes (KDIGO) stage 1 or higher AKI. Secondary outcomes include death, cardiopulmonary bypass time, bleeding, transfusion rates, prolonged mechanical ventilation, myocardial infarction, length of stay, and quality of life measures. Patients will undergo 1:1 block randomization to each treatment arm on day of surgery. Sequence of operation will be at the surgeon's discretion with mandatory guidelines for temperature and ACP administration. Perioperative management will occur as per enrolling center standard of care. Neurocognitive function will be assessed for neurological injury using validated neurological screening tests: NIHSS, MOCA, BI, and MRS throughout patient follow-up. Diagnosis and classification of AKI will be based on rising creatinine values as per the KDIGO criteria. Study duration for each patient will be 60 ± 14 days. DISCUSSION: It is hoped that performing hemiarch surgery using mild hypothermia (32 °C) and selective ACP will result in a 15% absolute risk reduction in the composite outcomes. The potential of this risk reduction will translate into improved patient outcomes, survival, and long-term financial savings to the health care system. In addition, the results of this trial will be used to create the first-ever guidelines for temperature management strategy during aortic surgery. TRIAL REGISTRATION: This trial is registered on ClinicalTrials.gov with the registration number NCT02860364. Registration date August 9th, 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jabagi H, Wells G, Boodhwani M, et al. COMMENCE trial (Comparing hypOtherMic teMperaturEs duriNg hemiarCh surgEry): a randomized controlled trial of mild vs moderate hypothermia on patient outcomes in aortic hemiarch surgery with anterograde cerebral perfusion. Trials. 2019. PMID: 31815641. doi:10.1186/s13063-019-3713-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。